INTRODUCTION
We recently reported that thrombin binds specifically to about 50,000 receptor sites on the surface of intact human platelets (1) . The kinetics of thrombin binding are complex in that the affinity of platelets for thrombin decreases as more thrombin is bound. This could be explained either by a negative cooperative interaction among receptors of a single kind or by multiple kinds of receptors with different affinities for thrombin. At this time the nature of the thrombin receptor(s) is unknown.
Native thrombin and thrombin inactivated with diisopropyl fluorophosphate (DIP-thrombin)' bind indistinguishably to platelet receptor sites (1) , although only the native, proteolytically active thrombin can initiate platelet aggregation and the release reaction (2), i.e., the rapid secretion of serotonin, calcium, adenine nucleotides, and certain other substances (3) . We observed that DIP-thrombin potentiates serotonin Mr. Tollefsen is the recipient of U. S. Public Health Service Medical Scientist Training Program Award GM 02016.
Received for publication 3 February 1975 and in revised form 4 April 1975. 1 Abbreviations used in this paper: DIP-, diisopropyl phosphoryl-; E-phytohemagglutinin, erythroagglutinating hemagglutinin of Phaseolus vulgaris.
release induced by submaximal levels of native thrombin, suggesting that thrombin binding per se might play a role in induction of the release reaction (1) .
To study the specificity of the binding of thrombin to platelets, we now have tested binding of the thrombin precursors, prothrombin and activation intermediates 1 and 2 (nomenclature of Owen, Esmon, and Jackson (4); see Fig. 1 ). These experiments indicate that the molecular conformation required for binding to platelets is present only after the final step in prothrombin activation.
METHODS
Platelets were isolated from human blood, washed, and suspended in isotonic Tris-saline (pH 7.5) containing glucose (1 mg/ml), as previously described (1) .
Bovine prothrombin, intermediate 1, and intermediate 2 were prepared as described previously (4, 5) . Purified prothrombin was cleaved by thrombin to yield intermediate 1 and fragment 1, which were separated by chromatography on QAE-Sephadex Q-50 (4). Intermediate 2 was prepared by incomplete activation of prothrombin with factor X. (without factor V and phospholipid) and was isolated by QAE-Sephadex chromatography (4). Bovine thrombin was purified by the method of Glover and Shaw (6) . The concentrations of these proteins were estimated by measurement of ultraviolet absorption with the following extinction coefficients: prothrombin, E'%,m, = 15. (4) .
The erythroagglutinating phytohemagglutinin of Phaseolus vulgaris (E-phytohemagglutinin) was prepared as described previously (7) .
Samples of proteins (5-10 Ahg) were prepared for gel electrophoresis by boiling for 2 min in 0.1 M sodium phosphate (pH 7.5), containing 5% sodium dodecyl sulfate and 0.1 M p-mercaptoethanol. Electrophoresis was carried out with 5% polyacrylamide gels containing 0.1%o sodium dodecyl sulfate and 0.1 M sodium phosphate (pH 7.5). The gels were stained for protein with Coomassie blue. Molecular weights of the proteins were determined by plotting the logarithm of molecular weight versus electrophoretic mobility, with the following molecular weight standards: serum albumin (mol wt 65,000), alkaline phosphatase (mol wt 43,000), aldolase (mol wt 40,000), pepsin (mol wt 35,000),
The Journal of Clinical Investigation Volume 56 July 1975-241-245 241 myoglobin (mol wt 17,200), and fibrinogen a, ft, and 'y chains (mol wt 63,500, 56,000, and 47,000, respectively).
Proteins were labeled with 'I by a modified Chloramine-T procedure (1) , and binding studies with platelets were performed with the Millipore filtration assay described previously (1) , with the following modification: incubations were terminated by adding 5 ml of isotonic Tris-saline (pH 7.5) and the platelet suspensions were immediately filtered under vacuum. This procedure took less than 5 s. No further washing of the filtered platelets was performed. A small amount of binding to the filters was observed in the absence of platelets. This "nonspecific" binding was proportional to added protein over the ranges studied and amounted to 0.7%, 1.0%, and 8.0% of the prothrombin, intermediate 1 labeled or labeled with 'I) and 2.5 gg of venom in 0.5 ml of isotonic Tris-saline (pH 7.5). Incubations were carried out for 4 h at room temperature, and the development of thrombin activity was followed by the fibrinogen clotting assay of Seegers and Smith (9) with purified bovine fibrinogen (10).
Release of [14C]serotonin from platelets was measured as previously described (1) .
RESULTS
The structural relationships among the proteins used in this study are diagramed in Fig. 1 (4) . The appearance of these intermediates and fragments during prothrombin activation in vitro has been elucidated previously (4, 5) and is discussed briefly below.
We prepared prothrombin, intermediates 1 and 2, and thrombin by previously published methods (4) (5) (6) .
To determine the purity of these preparations, we carried out polyacrylamide gel electrophoresis in the presence of sodium dodecyl sulfate and 8-mercaptoethanol (Fig. 2) FIGURE 4 Binding of 'I-prothrombin to platelets in the presence and absence of calcium. Incubations were performed as in Fig. 3 . '5I-Prothrombin was present along with the following additions: 0-0, none; *-*, 2 mM CaCl2; A-A, 0.1 U/ml thrombin; A-A, 0.1 U/ml thrombin + 2 mM CaCl2; Z-f[, 100 ,ug/ml E-phytohemagglutinin; *-*,100 ,g/ml E-phytohemagglutinin + 2 mM CaC12. The 'I-prothrombin was also activated with taipan venom and tested for binding in the absence of calcium (X-X). (Fig. 3, open symbols) . The bound material in each case was displaced (>80%) by 30 Ag/ml of unlabeled thrombin (data not shown). In these control experiments, the taipan venom was not removed before binding was tested, but we showed that the venom had no effect by itself on platelets (i.e., it did not induce aggregation or serotonin release) and that thrombin activity and the ability to bind to platelets appeared simultaneously during incubation with the venom.
The binding experiments were repeated at higher protein concentrations (up to 42-92 ug/ml), and no binding was observed with any of the precursors unless they were first converted to thrombin. Since prothrombin and fragment 1 have been shown to bind to phospholipid vesicles in a process requiring divalent cations (12), we also studied the binding of these two proteins to platelets in the presence of 2 mM calcium chloride. Prothrombin binding could not be detected in a range from 1.4 ng/ml to 84 Ag/ml in the presence of calcium ions, although the venom-activated protein did bind. This experiment is shown in Fig. 4 in the range 1.4-70 ng/ml. Similarly, fragment 1 did not bind either in the presence or absence of calcium ions (data not shown).
Platelets undergoing the release reaction in response to 0.1 U/ml of thrombin (1) or to 100 Ag/ml of Ephytohemagglutinin (7) also did not bind detectable prothrombin either in the presence or absence of calcium (Fig. 4) .
In additional experiments we observed that the thrombin precursors did not cause release of ['4C]serotonin from platelets at concentrations equivalent to 10 U/ml of thrombin (100-1,000-fold greater than normally required for release; ref. 1). The thrombin precursors at these concentrations also had no effect on 'Intermediate 2 could be activated fully by [Xa, Va, phospholipid, Ca++] in the presence of fragment 1-2 (11).
Binding of Prothrombin Activation Products to Human Platelets 243 the kinetics of thrombin-induced serotonin release or on "2'I-thrombin binding to platelets (tested at 0.02-0.1 U/ml thrombin). These observations are consistent with the lack of detectable binding of the thrombin precursors.
DISCUSSION
Our experiments demonstrate a high degree of specificity in the binding of thrombin to platelets. Neither prothrombin nor intermediates in the conversion of prothrombin to thrombin bind (Fig. 3) . It is particularly interesting that intermediate 2 does not bind, since hydrolysis of a single peptide bond (4) converts intermediate 2 to thrombin (see Fig. 1 ) and confers upon the protein its enzymatic as well as its platelet-binding properties. These properties apparently represent independent conformational changes in the protein, since the proteolytic active site of thrombin can be blocked with diisopropyl fluorophosphate while DIP-thrombin retains the ability to bind to platelets (1) . The finding that intermediates 1 and 2 also do not affect thrombin-induced serotonin release further implies that the accumulation of these intermediates during prothrombin activation does not modulate platelet function mediated by thrombin.
It is well established that phospholipid dispersions enhance the rate of prothrombin activation in vitro. Prothrombin and factor Xa both bind to phospholipid vesicles in a process requiring divalent cations, while thrombin does not bind. Gitel, Owen, Esmon, and Jackson have demonstrated that the fragment 1 region of the prothrombin molecule is required for binding to phospholipid vesicles (12) . It is generally assumed that platelets provide a catalytic surface similar to that of phospholipid vesicles for prothrombin activation in vivo.
The procoagulant activity of platelets (platelet factor 3) appears in response to a variety of platelet-aggregating agents (3) . Although the molecular basis of platelet factor 3 is not understood, one might predict by analogy to phospholipid vesicles that activated platelets would bind prothrombin in the presence of divalent cations.
In contrast to the above prediction, control platelet preparations or platelets that had undergone the release reaction in response to 0.1 U/ml of thrombin (1) or to 100 Ag/ml of E-phytohemagglutinin (7) rate were very rapid, such that a large fraction of the bound prothrombin dissociated within the time (< 5 s) taken for dilution and filtration of the platelet suspension. If prothrombin binding does take place, our data suggest that it is qualitatively very different from thrombin binding. A further possibility is that our washing procedure removes some factor necessary for prothrombin binding. Alternatively, platelets might bind prothrombin very tightly, so that the binding sites of our washed platelets would already be saturated with prothrombin. The receptor(s) for thrombin binding has not been identified. Using monovalent anti-fibrinogen antibody fragments (Fab), we have tested the hypothesis that platelet surface fibrinogen molecules bind thrombin. The Fab fragments bound to the platelet surface but had only a marginal inhibitory effect on the binding of thrombin, although they markedly inhibited platelet aggregation (13) . We concluded that platelet fibrinogen is required for thrombin-induced aggregation of washed platelets but probably does not constitute a major population of thrombin receptor sites.
Recent experiments in this laboratory have demonstrated a strong correlation between thrombin binding and the extent of ["C]serotonin release from platelets.
At a given total thrombin concentration, changes in the anionic composition of the buffer in which platelets were suspended resulted in large differences in the amount of thrombin bound, and the extent of serotonin release was directly proportional to the thrombin bound. The various buffers used did not appear to have a general effect on the platelet surface, since lectin-induced release (7) was not affected. Thrombin binding thus appears to be a highly specific process that is directly involved in induction of the platelet release reaction.
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